Full text is available at the source.
Abstract
Glucocorticoids are linked to glycaemic disturbances, including steroid-induced diabetes.
- Glycaemic disturbances range from transient hyperglycaemia to diabetes following glucocorticoid use.
- Insulin is the standard treatment for glycaemic dysregulation caused by glucocorticoids.
- There is potential for glucagon-like peptide-1 receptor agonists to be effective in managing glucocorticoid-induced dysglycaemia.
- The efficacy and safety of glucagon-like peptide-1 receptor agonists in this context have not been systematically evaluated.
Simplified